ConductScience.org, home

Gene · 23705

Papers3,480

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

301 to 320 of 3,480

Download this page as JSON
TitleJournalYearPMIDFound bySource
Single-cell RNA sequencing highlights the role of PVR/PVRL2 in the immunosuppressive tumour microenvironment in hepatocellular carcinoma.Front Immunol202337383234PubTator, text miningPubMed
EZH1/2 dual inhibitors suppress HTLV-1-infected cell proliferation and hyperimmune response in HTLV-1-associated myelopathy.Front Microbiol202337378292PubTator, text miningPubMed
Editorial: Editors' showcase 2021/2022: insights in cell adhesion and migration.Front Cell Dev Biol202337377736PubTator, text miningPubMed
Tumor Microenvironment Remodeling in Gastrointestinal Cancer: Role of miRNAs as Biomarkers of Tumor Invasion.Biomedicines202337371856PubTator, text miningPubMed
Research Progress of Dendritic Cell Surface Receptors and Targeting.Biomedicines202337371768PubTator, text miningPubMed
A Comprehensive Review of miRNAs and Their Epigenetic Effects in Glioblastoma.Cells202337371047PubTator, text miningPubMed
Integrating Multi-Omics Analysis for Enhanced Diagnosis and Treatment of Glioblastoma: A Comprehensive Data-Driven Approach.Cancers (Basel)202337370767PubTator, text miningPubMed
Single-cell sequencing in primary intraocular tumors: understanding heterogeneity, the microenvironment, and drug resistance.Front Immunol202337359513PubTator, text miningPubMed
Stromal circuits involving tumor-associated macrophages and cancer-associated fibroblasts.Front Immunol202337342322PubTator, text miningPubMed
Retrospective study of transcriptomic profiling identifies Thai triple-negative breast cancer patients who may benefit from immune checkpoint and PARP inhibitors.PeerJ202337334114PubTator, text miningPubMed
lncRNAs-EZH2 interaction as promising therapeutic target in cutaneous melanoma.Front Mol Biosci202337325482PubTator, text miningPubMed
Possible therapeutic targets for NLRP3 inflammasome-induced breast cancer.Discov Oncol202337300757PubTator, text miningPubMed
Hope and Hype around Immunotherapy in Triple-Negative Breast Cancer.Cancers (Basel)202337296893PubTator, text miningPubMed
New Biomarkers and Treatment Advances in Triple-Negative Breast Cancer.Diagnostics (Basel)202337296801PubTator, text miningPubMed
Somatic mutations of CADM1 in aldosterone-producing adenomas and gap junction-dependent regulation of aldosterone production.Nat Genet202337291193PubTator, text miningPubMed
Effects of acute low-moderate dose ionizing radiation to human brain organoids.PLoS One202337256873PubTator, text miningPubMed
Ulcerative colitis successfully treated with vedolizumab in the presence of comorbid opportunistic infections: a case report.J Med Case Rep202337254193PubTator, text miningPubMed
The vertebrate sialylation machinery: structure-function and molecular evolution of GT-29 sialyltransferases.Glycoconj J202337247156PubTator, text miningPubMed
Local Treatment of Triple-Negative Breast Cancer: Is Mastectomy Superior to Breast-Conserving Surgery?J Pers Med202337241035PubTator, text miningPubMed
Regulation of the Cell Cycle by ncRNAs Affects the Efficiency of CDK4/6 Inhibition.Int J Mol Sci202337240281PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/23705/papers?page=16